CSF2 and neoplasm: Preclinical studies in the 1990s demonstrated that irradiated tumor cells were not effective in generating anti-tumor immunity, but when modified to release granulocyte macrophage–colony-stimulating factor (GM-CSF), they were able to stimulate long-lasting anticancer immunological response [56].